Osaic Holdings’s Forte Biosciences FBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-20
Closed -$112 7484
2024
Q3
$112 Sell
20
-23
-53% -$237 ﹤0.01% 7236
2024
Q2
$582 Hold
43
﹤0.01% 6947
2024
Q1
$754 Hold
43
﹤0.01% 6742
2023
Q4
$712 Hold
43
﹤0.01% 6839
2023
Q3
$714 Hold
43
﹤0.01% 6917
2023
Q2
$1.12K Hold
43
﹤0.01% 6850
2023
Q1
$1.09K Hold
43
﹤0.01% 6922
2022
Q4
$2K Hold
43
﹤0.01% 6644
2022
Q3
$2K Buy
43
+20
+87% +$635 ﹤0.01% 6764
2022
Q2
$1K Sell
23
-10
-30% -$318 ﹤0.01% 7068
2022
Q1
$1K Buy
33
+14
+74% +$530 ﹤0.01% 7028
2021
Q4
$1K Buy
19
+14
+280% +$942 ﹤0.01% 7172
2021
Q3
$0 Sell
5
-14
-74% -$7.76K ﹤0.01% 7217
2021
Q2
$15K Buy
19
+10
+111% +$9.01K ﹤0.01% 5821
2021
Q1
$8K Buy
9
+3
+50% +$2.46K ﹤0.01% 5979
2020
Q4
$6K Buy
6
+1
+20% +$940 ﹤0.01% 5705
2020
Q3
$6K Buy
+5
New +$3.31K ﹤0.01% 5497
2020
Q2
Hold
0
6172
2020
Q1
Hold
0
6101

Other funds holding FBRX

Osaic Holdings's FBRX Position: Q4 2024 in Review

Osaic Holdings sold out of Forte Biosciences (FBRX) in Q4 2024, closing a stake of 20 shares — an estimated $112 sold.

Osaic Holdings first reported a position in FBRX in Q3 2020 and held it in 17 quarters. The position peaked at $15K in Q2 2021. 26 funds tracked by Wall St. Rank hold FBRX as of Q4 2024.

  • Osaic Holdings reported no remaining Forte Biosciences position as of Q4 2024 after selling out during the quarter.
  • Osaic Holdings sold 20 Forte Biosciences shares in Q4 2024, an estimated $112.
  • Osaic Holdings first reported a position in Forte Biosciences in Q3 2020 and held it in 17 quarters.
  • Osaic Holdings's Forte Biosciences position peaked at $15K in Q2 2021.
  • 26 funds tracked by Wall St. Rank held Forte Biosciences as of Q4 2024.

Based on Osaic Holdings's 13F filing for Q4 2024, filed 7 Feb 2025.